semaglutide and compounding pharmacies Drugmakers battle over compounded Ozempic Zepbound : Shots FDA Moves to Permanently Close

Food breakdown, fermentation, reflux, slowed motility, infection, or another digestive problem may contribute

An observational study published in 2023 in Diabetes Care that looked to determine whether the use of GLP-1 medications was associated with an increased risk of thyroid cancer found that in 1-3 years of treatment, the risk for thyroid cancer was increased for those taking GLP-1 medications (2)

This study has several acknowledged limitations

Moreover, some studies have suggested that L-Carnitine can improve insulin sensitivity and there is burgeoning interest in its use in individuals with type 2 diabetes

But those are averages, and the range is wide

Eular recommendations for the management of systemic lupus erythematosus: 2023 update